Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

力平之 - NMPA Drug Approval Details

Approvals/NMPA/Fenofibrate Capsules

Approved

化学药品

Fenofibrate Capsules

Abbott Laboratories Limited🇨🇳 National Medical Products Administration

Approval Date: Oct 14, 2022
Approval ID: 1xpZsGUOTYm
Company: Abbott Laboratories Limited
Type: 化学药品

Approval Details

Approval Id: 1xpZsGUOTYm
Approval Number: 国药准字HJ20181240
Generic Name: 非诺贝特胶囊
Generic Name En: Fenofibrate Capsules
Trade Name: 力平之
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 200mg
Reg Date: 2022-10-14
Expired Date: 2027-10-13
Company Name: Abbott Laboratories Limited
Company Detail Path: /organization/abbott-laboratories-limited

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 14, 2022

Approval ID

1xpZsGUOTYm

Type

化学药品

Back to NMPA Approvals